SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

EXL Elixinol Wellness Limited

Healthcare · Drug Manufacturers - Specialty & Generic · website
$0.01
52wk 0.01 – 0.02
Overall
48.9
Value
100.0
Growth
69.5
Health
29.2
Quality
0.0
Momentum
28.2
Dividend
—
Price
About Elixinol Wellness Limited

Elixinol Wellness Limited, a holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. The company offers its products under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributes its products through grocery, wholesale, and e-commerce channels for white label customers, as well as food, beverage, and beauty manufacturers. In addition, the company engages in the manufacture and distribution of hemp-derived cannabidiol (CBD) products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is based in Newtown, Australia.

Price analytics

Returns

1 day 16.7%
1 week -12.5%
1 month -12.5%
3 months 16.7%
6 months 0.0%
1 year -50.0%
3 years -85.9%

Risk

Volatility (1y ann.) 166.5%
Beta vs ASX 200 -0.75
Sharpe (1y) 0.25
VaR 95% (1-day) -12.5%
Max drawdown (1y) -62.5%
Off 1-year high -56.3%

Technicals

RSI(14) 42
vs 50DMA -0.1%
vs 200DMA -12.7%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 100.0
Trailing P/E
—
Forward P/E
100
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
100
Growth 69.5
Revenue growth (1y)
39
Revenue CAGR (3y)
100
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 29.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
0
Debt / Equity
76
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 28.2
6-month return vs ASX 200
46
Price vs 200-day average
8
Price vs 50-day average
49
Position in 52-week range
6

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$3.18M
P/E (trailing)
—
P/E (forward)
-0.70
EPS (trailing)
-0.01
Dividend yield
—
Payout ratio
0.0%
Beta
2.21
EV / EBITDA
-2.85
Price / Book
0.47
ROE
-53.0%
Operating margin
-8.7%
Net margin
-21.9%
Total cash
$996,000
Total debt
$4.03M
Current ratio
0.78
Debt / Equity
0.63
Free cash flow
$-878,375
Avg volume
452,361
Latest annual results (FY ending 31 Dec 2025)
  • Revenue$15.50M
  • Gross profit$6.00M
  • Operating income-$5.98M
  • Net income-$5.50M
  • Diluted EPS-0.02
  • Free cash flow-$3.31M
  • Net debt$2.32M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4